WHO alerts
WHO medical product alerts affecting India
Last checked 20 September 2026. Source: WHO substandard and falsified medical products alerts
WHO issues a Global Medical Product Alert when a substandard or falsified product is detected in the supply chain. The alerts below name an Indian manufacturer, an Indian-made product, or a falsified product found in India.
| Alert | Date | Products | Manufacturer (as named) | India link |
|---|---|---|---|---|
| N°5/2025 | 13 October 2025 | Coldrif syrup, Respifresh TR syrup, ReLife syrup | Sresan Pharmaceutical, Kancheepuram, Tamil Nadu, India; Rednex Pharmaceuticals, Ahmedabad, Gujarat, India; Shape Pharma, Gujarat, India | Domestic incident: child deaths in Madhya Pradesh and Rajasthan; manufacturers in Tamil Nadu and Gujarat; WHO found no evidence of export |
| N°3/2025details under verification | 14 May 2025 | IMFINZI (durvalumab) 500 mg/10 ml injection, three falsified lots (numbers: see WHO alert) | Genuine product: AstraZeneca | Follows N°5/2024, whose falsified lot was later found in India; countries for these lots to be verified |
| N°5/2024 | 23 December 2024 | IMFINZI (durvalumab) 500 mg/10 ml injection, lot BAVX, falsified | Genuine product: AstraZeneca | The August 2025 update to the alert reported the falsified lot found in India, Pakistan and Uzbekistan |
| N°6/2023 | 7 August 2023 | Cold Out syrup (paracetamol + chlorpheniramine) | Fourrts (India) Laboratories Pvt. Ltd, for Dabilife Pharma Pvt. Ltd, India | Manufactured in India by Fourrts Laboratories for Dabilife Pharma; identified in Iraq |
| N°5/2023 | 19 July 2023 | Naturcold syrup | Labelled 'Fraken International (England)'; traced by the Government of India to Riemann Labs, Indore | Government of India told Parliament the syrup was made by Riemann Labs, Indore, which was directed to halt manufacture |
| N°4/2023 | 25 April 2023 | Guaifenesin Syrup TG | QP Pharmachem Ltd, Punjab, India; marketed by Trillium Pharma, Haryana, India | Manufacturer in Punjab and marketer in Haryana; product found in the Marshall Islands and the Federated States of Micronesia |
| N°2/2023 | 22 February 2023 | Tetracycline Hydrochloride Ophthalmic Ointment USP 1% | Galentic Pharma (India) Pvt. Ltd, Navi Mumbai, India | Manufacturer in Navi Mumbai; distributed to about 55 countries through humanitarian medical kits |
| N°1/2023 | 11 January 2023 | Ambronol syrup, DOK-1 Max syrup | Marion Biotech Pvt. Ltd, Uttar Pradesh, India | Manufacturer in Noida, Uttar Pradesh; products exported to Uzbekistan and linked to child deaths; UP licence cancelled March 2023 |
| N°8/2022details under verification | 27 December 2022 | METHOTREX 50 mg | , being verified | Unclear, the content plan lists this alert with the manufacturer and country to be verified from the WHO annex |
| N°6/2022 | 5 October 2022 | Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, Magrip N Cold Syrup | Maiden Pharmaceuticals Limited, Haryana, India | Manufacturer in Sonipat, Haryana; products exported to the Gambia and linked to child deaths from acute kidney injury; Haryana halted production |
| N°2/2022 | 9 March 2022 | DESREM (remdesivir) 100 mg injection, falsified | Genuine product: Mylan Laboratories, India | Falsified vials found in India and Guatemala; the genuine product is made in India by Mylan |